5
Total deals
$240.0M
Total value
$120.0M
Avg deal
$225.0M
Largest
| # | Acquired | Date | Type | Status | Price | |
|---|---|---|---|---|---|---|
| 1 |
Altucell
Altucell is a biotech company fulfilling an"unmet need" in cell, molecular and r…
|
2019-11-25 | Acquisition | Complete | — | Deal → |
| 2 |
Medisource Partners
Medisource Partners is an FDA-registered distributor of medical and surgical pro…
|
2019-01-10 | Acquisition | Complete | — | Deal → |
| 3 |
Regentys
Regentys is a development stage, regenerative medicine company focused on develo…
|
2019-01-07 | Acquisition | Complete | $15.0M | Deal → |
| 4 |
Olaregen Therapeutix
Olaregen Therapeutix is a Biotechnology company.
|
2018-11-28 | Acquisition | Complete | — | Deal → |
| 5 |
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare di…
|
2017-01-23 | Acquisition | Complete | $225.0M | Deal → |